PSMA-PET/CT Shows Promise

A trial at the University Hospital Bonn in Germany has found that PSMA-PET/CT scans could help clinicians make better treatment decisions for high-risk prostate cancer patients by offering additional information beyond standard imaging techniques, but there were also false positives in 6% of patients that required further investigation.